Benefits of Partnering
The KineMed translational medicine (TM) and personalized medicine (PM) platform offers a wide range of benefits to our partners. Significantly, we provide greater clarity earlier and less expensively than either traditional development paradigms or alternative emerging approaches. We typically can provide proof of concept data for less than a tenth the cost and in a fifth the time offered by alternative approaches. Partnerships also additionally benefit KineMed by allowing us to continue to validate our TM & PM platforms and providing access to investigational drugs and clinical data.
By partnering with KineMed, pharmaceutical R&D departments are able to:
- Eliminate candidates likely to fail
- Advance candidates likely to succeed
- Rapidly demonstrate therapeutic activity in humans
- Enrich product pipelines
- Design better clinical trials through well-defined patient stratification, dosing regimens and endpoint delineation
- Increase the output of superior medicines